![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 29, 22284-22292, July 21, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 7, 2000, and in revised form, May 2, 2000
Enamel biomineralization is a complex process
that involves interactions between extracellular matrix proteins. To
identify proteins interacting with tuftelin, a potential nucleator of
enamel crystallites, the yeast two-hybrid system was applied to a mouse tooth expression library and a
tuftelin-interacting protein (TIP) was isolated for further characterization. Polyclonal antibodies were
prepared against two recombinant variants of this protein. Both
antibodies identified a major protein product in tooth organs at 39 kDa, and this protein has been called TIP39. Northern analysis showed
TIP39 messenger RNA in multiple organs, a pattern similar to that of
tuftelin messenger RNA. In situ hybridization of mandibles of 1-day-old mice detected TIP39 RNA in secretory ameloblasts and
odontoblasts. Immunolocalization of TIP39 and tuftelin in cultured
ameloblast-like cells showed that these two proteins colocalize. Within
the developing tooth organ, TIP39 and tuftelin immunolocalized to the
apical pole of secretory ameloblasts (Tomes' processes) and to the
newly secreted extracellular enamel matrix. TIP39 amino acid sequence
appears to be highly conserved with similarities to proteins in species
as diverse as yeast and primates. Available sequence data and the
findings reported here suggest a role for TIP39 in the secretory
pathway of extracellular proteins.
Enamel is the bioceramic composite covering of vertebrate teeth
that is unique in many ways (1, 2). Unlike most mesenchyme-derived, collagen-based biomineralized tissues, enamel is created by an ectoderm-derived cell lineage, ameloblasts (3). Ameloblasts synthesize
and secrete an organic extracellular matrix that is devoid of collagen
(4). Moreover, the matrix is proteolytically destroyed and removed by
ameloblasts while being simultaneously replaced by inorganic carbonated
hydroxyapatite crystallites, a process that creates the hardest tissue
in the vertebrate body (5).
The most abundant protein of the forming enamel is amelogenin, a family
of hydrophobic proteins that are synthesized in response to a cascade
of signals, elicited as part of the epithelial-mesenchymal interactions
that characterize all developmental aspects of odontogenesis (6, 7).
Although significant strides have been made in understanding the
developmental mechanisms contributing to odontogenesis (8, 9), less has
been accomplished in our understanding of the role of the organic
matrix in directing the habit of the mineral phase of enamel.
Currently, several classes of structural enamel proteins are known:
amelogenin (10), ameloblastin (11, 12), enamelin (13), and tuftelin
(14-16). Amelogenin has been shown to undergo self-assembly into
nanospheres, some 20-nm spheroid structures that are interspersed among
the long hydroxyapatite crystals (17). The relationship of the other
enamel proteins to the abundant amelogenin nanospheres, if any, is not
yet appreciated. However, tuftelin has been postulated to serve a role
in crystallite nucleation based on its physicochemical characteristics,
as well as its localization to the newly secreted enamel matrix (4,
18).
Organizing the enamel extracellular matrix is thought to be largely a
process of self-assembly since it occurs in the extracellular milieu.
We have shown (19) that amelogenin and tuftelin each have the capacity
for self-assembly but do not appear to interact with one another. Our
strategy was to use the yeast two-hybrid assay to search for previously
unknown proteins that participate in organizing the enamel
extracellular matrix based on the supposition that such proteins may
play critical roles during replacement by the inorganic crystallites.
By using tuftelin as a bait protein, we identified several
tuftelin-interacting proteins
(TIP)1 (20). In the
developing tooth, a tuftelin-interacting
protein, with an apparent molecular mass of approximately
39 kDa (TIP39) was localized to the apical portion of the
secretory ameloblasts, a location that may exert considerable influence
on enamel protein secretion and assembly, suggesting that TIP39 plays a
role in amelogenesis.
DNA Sequencing of TIP39--
The sequencing strategy for TIP39
involved primer walking, that is using multiple oligonucleotide primers
designed and prepared as additional sequence information became
available. Complementary DNA nucleotide sequences for two clones
(identified previously as plasmids pTIP-10 and pTIP-33) (20) were
determined from both the 5'- and 3'-directions using previously
published methodology (20, 21). These two cDNA clones code for
TIP39 with one containing more 5'-sequence information (pTIP-33).
Unless otherwise stated, data presented in this paper are derived from
the smaller of the two cDNA clones (pTIP-10). Both cDNA
sequences were entered into the GenBankTM data base
(accession numbers AF097181 and AF156852).
Plasmids Prepared to Identify Tuftelin and TIP39 Binding-domains
Using the Yeast Two-hybrid System--
Bovine tuftelin cDNA
(kindly supplied by Dr. Dan Deutsch) (22) was cloned into plasmid pAS2
(CLONTECH, Palo Alto, CA) using oligonucleotide
primers SN103 and SN110 (Table I) to
produce the plasmid pbTuft-(1-389) containing the bovine tuftelin
amino acids 1-389 (19, 20). Plasmid pbTuft-(1-389) was then shortened by removing the carboxyl-terminal region, either by digesting the
vector with restriction enzymes EcoNI and SalI to
remove 494 base pairs from its 3'-region (coding amino acids 226-389),
blunt-ending the remaining linear DNA and religating the ends, or by
digesting with restriction enzyme PstI to remove 785 base
pairs from the 3'-region (coding amino acids 133-389) and religating
the resulting linear DNA. The new plasmids created were called
pbTuft-(1-225) and pbTuft-(1-132), respectively. Plasmid
pbTuft-(1-225) codes for bovine tuftelin amino acids 1-225, and
plasmid pbTuft-(1-132) codes for bovine tuftelin amino acids
1-132.
In addition to the studies of protein interactions with bovine
tuftelin, the mouse tuftelin cDNA (kindly provided by Dr. Mary MacDougall and Dr. Jim Simmer; GenBankTM accession number
AF047704) was also included in this study. Oligonucleotide primers
SN234 and SN235 (Table I) were used in a PCR to amplify mouse tuftelin
cDNA from a plasmid DNA template to include its entire open reading
frame (16). The PCR product was digested with restriction enzymes
SmaI and BamHI, and the resulting purified DNA
product was cloned into pAS2 at these same restriction sites. This new
mouse tuftelin containing plasmid was called pmTuft-(1-390) and codes
for mouse tuftelin amino acids 1-390 (Tables
II and III)
(16). Oligonucleotide primers SN245 and SN235 (Table I) were used in a
PCR to amplify a partial mouse tuftelin cDNA. The PCR product was
digested with restriction enzymes SmaI and BamHI,
and the resulting purified DNA product was then cloned into pAS2 at
these same restriction sites. The resulting tuftelin containing plasmid
was called pmTuft-(165-390) and codes for mouse tuftelin amino acids
165-390 (Tables II and III). Oligonucleotide primers SN246 and SN235
(Table I) were used in a PCR to amplify a further reduced mouse
tuftelin cDNA. The PCR product was digested with restriction
enzymes SmaI and BamHI, and the resulting product was then cloned into pAS2 at these same restriction sites. The resulting tuftelin-containing plasmid was called pmTuft-(294-390) and
codes for mouse tuftelin amino acids 294-390 (Tables II and III).
The plasmids pAD-GAL4 (Stratagene, La Jolla, CA) and pTIP-10 (20) were
used to prepare a number of plasmids for which either the 5'- or
3'-regions of TIP39 were removed. Plasmids from which the carboxyl
termini were to be removed were digested with restriction enzymes to
cut and remove carboxyl-terminal fragments of DNA. Digesting plasmid
pTIP-10 with restriction enzymes BamHI and BglII and ligating the resulting linear DNA produced plasmid pTIP-10-(1-208) (Fig. 1) which included pTIP-10 cDNA
up to the first BamHI restriction site. Numbering within
parentheses relates to an open reading frame identified within the
plasmid pTIP-10 (Fig. 1). Digesting pTIP-10 with restriction enzyme
XhoI and ligating the resulting linear DNA resulted in the
plasmid pTIP-10-(1-131) (Fig. 1). Three additional plasmids were
prepared to exclude the amino-terminal region. Oligonucleotide primers
SN227 and either SN228, SN229, or SN230 (Table I) were used in PCR
amplifications using pTIP-10 as the template DNA. The three resulting
PCR-amplified DNA products were digested with restriction enzymes
EcoRI and XhoI and cloned into the pAD-GAL4
vector at the EcoRI and XhoI multicloning site. The resulting plasmids were called pTIP-10-(193-526),
pTIP-10-(333-526), and pTIP-10-(412-526), respectively (Table
III).
Assessing Protein-Protein Interaction by Polymerase Chain Reaction, Ligation, and Transformation
Conditions--
PCRs, ligations, and transformations were performed as
described elsewhere (23). For each construct involving PCR-generated DNA, the correct insert orientation and reading frame was confirmed by
sequencing through the union of plasmid and the insert DNA.
Preparation of the Digoxygenin-labeled RNA Probes for in Situ
Hybridization for TIP39--
The 5'-, 492-base pair region of the
plasmid pTIP-10 (EcoRI through XhoI restriction
sites; Fig. 1) was further subcloned into pGem7zf(+) (Promega Corp.,
Madison, WI) to allow for the preparation of RNA probes for this
in situ analysis (23). This plasmid was named pGTIP-10 (20).
DNA was used as the template for the synthesis of the
digoxygenin-labeled RNA probes by restriction digest of pGTIP-10 with
either EcoRI or XhoI (23, 24). T7 RNA polymerase
was added to the EcoRI cut DNA to generate the antisense
probe, and SP6 RNA polymerase was added to the XhoI prepared
DNA to generate the sense probe (24). Probe synthesis, purification,
and storage are described elsewhere (24).
Preparing Mouse Tissue for in Situ Analysis--
One-day-old
postnatal B6CBA mouse pups (supplied by The Jackson Laboratory) were
sacrificed according to the University of Southern California approved
guidelines. Mandibles were excised and split mid-sagittally. Specimens
were fixed overnight in 4% paraformaldehyde at 4 °C, washed for 30 min (twice) in phosphate-buffered saline (pH 7.4 and 4 °C), and
dehydrated. To begin the embedding process, specimens were incubated in
50% xylene and 50% paraffin for 30 min (twice) and in paraffin for 20 min (three times) in a 58 °C oven with a vacuum pressure of In Situ Hybridization--
Pre-hybridization, hybridization,
post-hybridization washes, and post-hybridization treatment have been
described previously (24).
Assessing TIP39 Gene Expression by Northern Analysis--
A
Northern blot membrane containing poly(A)-RNA from selected organs was
purchased from Stratagene (La Jolla, CA). Radiolabeled TIP39 cDNA
isolated from pGTIP-10 (base pairs 1-492) (20) or PCR-generated
cDNA using plasmid pTIP-10 as template DNA (base pairs 1093-1675;
using oligonucleotide primers SN229 and SN227) (Table I) was prepared
using a random priming DNA labeling kit (Roche Molecular Biochemicals).
Northern analysis was performed as described elsewhere (23).
Assessing TIP39 Gene Expression by RT-PCR--
Timed pregnant
Swiss Webster mice were sacrificed at selected embryonic stages (E,
measured in days after copulation) of development, corresponding to
E14-E18. One-day-old postnatal pups were similarly prepared. The
mandibles of these fetuses or pups were removed and combined with
RNAzol B (Tel-Test, Inc., Friendswood, TX) at a concentration of 2.0 ml
per 100 mg of tissue. All tissue was homogenized on ice with an
electric homogenizer (Tissue Tearor, model number 985-370, Biospec
Products Inc., Racine, WI). The homogenate was combined with chloroform
(0.2 ml chloroform per 2.0 ml homogenate), vortexed, and placed on ice.
The samples were subsequently centrifuged, and the aqueous phase was
placed into a fresh tube with an equal volume of isopropyl alcohol and
stored at Recombinant Proteins to TIP39 and Antibody Production--
The
plasmid pTIP-10 was used as template DNA in a PCR to generate a
1-kilobase pair DNA fragment that covered an internal coding region of
TIP39. Oligonucleotide primers SN211 and SN209 (Table I) were prepared
containing either a BglII (SN211) or SalI (SN209)
restriction enzyme site to allow for the direct cloning of the PCR
product into the protein expression vector pQE32 (Qiagen Inc.,
Valencia, CA). The vector pQE32 (containing a polyhistidine and
amino-terminal) and PCR-derived DNA were both prepared by restriction
cutting with BamHI and SalI, ligated, and
transformed into bacteria. The resulting recombinant TIP39 protein has
been called rTIP41 because it has a predicted molecular mass of 40.8 kDa. Recombinant TIP41 protein was prepared and recovered using nickel-nitrilotriacetic acid metal affinity chromatography using the
protocol supplied by Qiagen. The purity and apparent molecular weight
of the recombinant protein were verified on a polyacrylamide gel (Fig.
2), and the recovered mass was
quantitated by Lowry determination. A fraction of the protein was sent
to an independent laboratory for sequencing and confirmed that it
corresponded to the predicted amino acid sequence of the TIP39 protein.
Polyclonal antibodies to rTIP41 were produced in chickens using
standard immunization strategy (Research Genetics, Inc., Huntsville,
AL).
In a similar methodology, a second recombinant TIP39 protein was
prepared from the entire coding region of the plasmid pTIP-33. The
resulting recombinant protein has been called rTIP78 because it has a
predicted molecular mass of approximately 78 kDa. The purity and
apparent molecular mass of rTIP78 were verified on a polyacrylamide gel
prior to use (Fig. 2). Polyclonal antibodies to the rTIP78 were
produced in chickens using standard immunization strategy (Research
Genetics, Inc.). IgY antibodies were recovered from purified egg yolks
(25).
Western Detection of TIP39 in Tooth Organs--
Detailed methods
for protein detection were used as published (26). In brief, total
protein was recovered from 1-day-old mouse tooth organs and loaded and
resolved to size using 10% SDS-polyacrylamide gel electrophoresis.
Recombinant TIP41 and rTIP78 were included as positive controls. The
gel was electrotransferred to polyvinylidene fluoride membrane
(Millipore, Bedford, MA) and blocked extensively (with 1% albumin and
1% goat serum), and TIP39 epitopes were detected using chicken
polyclonal antibodies raised against rTIP41 or rTIP78 at a dilution of
1:3,000 at room temperature overnight.
Immunolocalization--
Sagittal sections of 1-day-old
post-natal mouse mandibles including tooth germs were prepared in
6-µm sections for immunohistochemistry. Details of immunolocalization
methodology are covered elsewhere (25). Bovine tuftelin anti-peptide
polyclonal antibodies (kindly provided by Dr. Dan Deutsch) were
prepared against the following peptides: DGHEEIIKVYLKGRS,
QSKDTTIQELKEKIA, and SGLRRSPPPLEAASPDFD (16, 22). The first two of
these peptide sequences are also found in the mouse tuftelin protein,
whereas the third peptide is unique to the bovine tuftelin (22).
Polyclonal antibodies (kindly supplied by Dr. Mary MacDougall and Dr.
Jim Simmer) were prepared to a recombinant mouse tuftelin protein.
Mouse amelogenin polyclonal antibodies (kindly supplied by Dr. Jim
Simmer and Dr. Alan Fincham) were prepared to the recombinant M179
protein (26). Unless otherwise stated a dilution of 1:3000 was used for
the rTIP41 and rTIP78 antibodies, a dilution of 1:2000 was used for the
bovine tuftelin anti-peptide antibody, and a 1:400 dilution was used
for the mouse tuftelin antibody.
Immunofluorescence--
The mouse ameloblast-like cell line, LS8
(27, 28), was cultured on polylysine-coated coverslips at a density of
1.5 × 105 cells per well and allowed to grow
overnight in a 37 oC incubator in preparation for
immunofluorescence studies (29). Cells were washed in Hanks' buffer
twice and fixed with HistoChoice (Amresco, Solon, OH). Cells were
blocked with 10% normal goat serum, 10% normal donkey serum, and 10%
bovine serum albumin for 1 h, and washed once with
phosphate-buffered saline and three times with 0.1% Triton X-100.
Cells were incubated with the primary antibody against TIP39 (the
recombinant TIP41 protein) and then incubated with the secondary
antibody (rhodamine donkey anti-chicken IgY, Jackson ImmunoResearch,
West Grove, PA) for 1 h. These same cells were then incubated with
the primary antibody against recombinant mouse tuftelin for 1 h
and then incubated with the secondary antibody (Alexa
FluorTM 488 goat anti-rabbit IgG; Molecular Probes, Eugene,
OR) for 1 h. Cells were then washed. Once this was complete the
slides were then mounted (ProLong Antifade Mounting Material, Molecular
Probes) for fluorescence microscopy. The images that were photographed are representative of the images observed.
DNA Sequence and a Predicted Protein Sequence for
TIP39--
Plasmids pTIP-10 and pTIP-33 were isolated from a 1-day-old
mouse tooth cDNA expression library based on the ability of the proteins they encode to interact with mouse or bovine tuftelin (20).
Plasmids pTIP-10 and pTIP-33 are partial cDNAs and code for the
same protein which we call TIP39, based on its apparent molecular
weight as determined by Western analysis. The pTIP-33 cDNA is the
larger of the two clones and contains more 5'-end nucleotide sequence
information. Complementary DNA (Table IV) and genomic DNA corresponding to the human homologue of TIP39 have
recently been sequenced (GenBankTM accession numbers
AL050258 and Z95115), and thus intron-exon boundaries could be
estimated for mouse TIP39. The human homologue is located on chromosome
22q12.1. The human sequences suggest that pTIP-33 lacks approximately
690 nucleotides from the 5'-region, including approximately 425 nucleotides that are in an open reading frame. The human homologue to
mouse TIP39 codes a 3590-nucleotide message with an (unmodified) open
reading frame of 96.8 kDa. The mouse TIP39 and its human homologue do
not contain a recognizable leader sequence suggesting an intracellular
function for the TIP protein.
Western Detection of TIP39--
Western analysis was performed on
protein extracted from molar teeth of 1-day-old mice using antibodies
produced against rTIP41 and rTIP78. Results from these Western blots
produced a dominant band at 39 kDa and additional minor bands ranging
between 33 and 36 kDa (Fig. 2, lanes 1 and 4).
Both antibodies produce identical results. A Western blot from porcine
tooth organ proteins was incubated with the antibody against rTIP41 and
resulted in a band at approximately 38-40 kDa (data not shown). No
cross-reactivity was seen with either antibody to the amelogenin
protein (approximately 22 kDa; Fig. 2, lanes 1, 2, and
4). The amelogenin protein is abundant in the tooth organ at
this stage of development and was used as an additional (negative)
control. A single band was evident at the predicted weight for the
respective recombinant proteins used as positive controls (Fig. 2,
lanes 3 and 5, respectively).
TIP39 Interacts with the Carboxyl Region of Tuftelin--
A series
of experiments were performed to determine the protein regions
responsible for the binding activity between tuftelin and TIP39. In
addition, the mouse-derived tuftelin cDNA was also used to
corroborate findings determined from the interaction observed with
bovine-derived tuftelin. Plasmid constructs containing defined regions
for either TIP39 or tuftelin were prepared (Table III), and
double-plasmid combinations were transformed into yeast strain PCY2
(19, 30). The yeast two-hybrid filter assay was used to determine
positive or negative protein-protein binding activities. All
combinations were transformed together, streaked on the same filter,
and assessed together for
Both bovine tuftelin and mouse tuftelin interact with TIP39 with equal
avidity (Table III, lines A and D), and the carboxyl terminus of
tuftelin is responsible for this interaction (Table III, line F).
Deleting the carboxyl-terminal 164 amino acids from the bovine tuftelin
(construct pbTuft-(1-225)) completely abolished the ability of
tuftelin to interact with TIP39 (Table III, line B). Deleting the
amino-terminal 293 amino acids from mouse tuftelin (construct
pmTuft-(294-390)) did not diminish the strength of the interaction
between tuftelin with TIP39 (Table III, line F). Stated differently, in
isolation, mouse tuftelin amino acids 294-390 (construct
pmTuft-(294-390)) interacted with similar avidity to TIP39 as did the
complete tuftelin protein (both mouse and bovine) when assayed with
TIP39 (Table III, line F verses lines A or D). These results are
similar to our previous study which showed that the carboxyl-terminal
region of bovine tuftelin was involved with tuftelin self-assembly
(31). Results also showed that all of the TIP39 deletion constructs
failed to react with intact tuftelin (Table III, lines G-K),
suggesting that the TIP39 interaction with tuftelin is related to its
tertiary or quaternary structure, rather than its secondary structure.
Northern Analysis--
Two unique TIP39 32P-labeled
double-stranded DNA probes, prepared from either the 5'-end or the
3'-end of pTIP-10 (nucleotides 1-492 and 1093-1675 respectively),
each identified two hybridization bands on a multiple organ adult mouse
poly(A)-RNA Northern blots (Table I and Fig.
3). The hybridization pattern was
identical for both probes. The two bands detected were approximately
3.9 kilobases (kb) and 3.1 kb in heart, brain, spleen, lung, liver, skeletal muscle, kidney, and testis. The blot was re-probed with In Situ Results for TIP39--
In situ hybridization
was used to localize the mRNA corresponding to the TIP39 protein
within mandibles of 1-day-old mouse pups. Messenger RNA was detected in
the developing incisor region (Fig.
4A). TIP39 showed high levels
of expression in the secretory ameloblasts and odontoblasts and lower
levels of expression in the cells of the stratum intermedium and
surrounding tissues of non-dental origin (Fig. 4A). An
identical pattern of expression was also observed in molars (not
shown). A sense RNA probe to TIP39 was prepared and used as a negative
control (Fig. 4B), and no background signal was evident.
RT-PCR--
Timed pregnant Swiss Webster mice were sacrificed on
days corresponding to selected embryonic stages of development
(E14-E18). The RNA from the mandibles, including the tooth germs, was
prepared from these embryos. TIP39 exon and intron boundaries were
determined by comparing the mouse TIP39 cDNA to its human homologue
(GenBankTM accession number AL050258) for which genomic
sequence is available. Oligonucleotide primers SN228 (exon 11 forward
primer; Table I) and SN209 (exon 14 reverse primer; Table I) were
selected and used because each is contained within different exons
allowing for discrimination between first strand cDNA derived from
mRNA as opposed to template derived from genomic DNA. The plasmid
pTIP-10 was subjected to similar analysis with SN228 and SN209, and the predicted 604-base pair product was determined by gel electrophoresis (Fig. 5, lane 2). RT-PCR using
the RNA prepared from the developmentally staged mandibles (E14-E18)
produced amplified products of the same size as the plasmid control
(Fig. 5). The DNA product from a single RT-PCR was subcloned, and the
nucleotide sequence was determined to show that the amplified DNA
corresponded to TIP39 (as previously determined from pTIP-10). Mouse
kidney-derived RNA was included as a non-tooth organ since TIP39 RNA
was found in multiple organs by Northern analysis. TIP39 RNA was
confirmed as a mouse kidney transcript by RT-PCR (Fig. 5, lane
4). A RT-PCR containing no RNA was included as a negative control,
and no amplified product was observed (Fig. 5, lane 3).
Colocalization of TIP39 and Tuftelin to the Apical Poles of
Secretory Ameloblasts--
Immunohistochemical studies using the
antibody made to a recombinant TIP39 protein on tissue sections from
2-day-old postnatal mouse molars indicate that the TIP39 protein
localizes to the apical regions of the ameloblasts and to the newly
formed enamel matrix (Fig. 4, C and D). In
particular TIP39 appears to coat (3-4 µm) spheres, which are likely
to be membrane involutions of Tomes' processes, the
secretory-apical-pole of ameloblast cells (Fig. 4C, arrows).
Tuftelin antipeptide polyclonal antibodies were used for
immunohistolocalization studies on 2 day-old post-natal mouse mandibles
(Fig. 4E). Tuftelin localized to the apical region of the
ameloblasts and to the newly formed enamel matrix that extends to the
dentino-enamel junction (Fig. 4E). Tissue sections in which
the primary antibody was omitted and the secondary antibody alone was
used were included as negative controls and revealed no staining (data
not shown). Immunofluorescence on LS8 cells (27, 28) using TIP39 and
tuftelin antibodies showed colocalization within the cell cytoplasm
(Fig. 4, F and G). TIP39 is evident within the
cell nucleus (Fig. 4, F and H).
Enamel formation is unique in that an almost completely
mineralized tissue replaces a protein matrix produced by the secretory ameloblast cells. To date amelogenins, tuftelin, ameloblastin, and
enamelin have been implicated in the process of enamel
biomineralization. Tuftelin-interacting proteins (TIPs) may represent
an additional class of proteins essential to enamel matrix secretion
and subsequent enamel crystallite formation (20). Support for the TIPs
playing a role in tooth formation can be seen in the TIP mRNA
expression profiles in cells of tooth lineage, notably ameloblasts and
odontoblasts (20). The ability of the TIPs to interact directly with
tuftelin suggests that protein to protein interactions may play a
general role in the assembly of the enamel extracellular matrix and
during enamel biomineralization. In this study, TIP39 mRNA is
localized to the ameloblasts as is evident by in situ
hybridization. TIP39 mRNA is also evident in odontoblasts, and
lesser amounts of TIP39 mRNA are seen in the cells of the stratum
intermedium. TIP39 mRNA appears to be present as two isoforms, one
at 3.1 kb and the other at 3.9 kb. The larger mouse TIP39 isoform is
similar in size (within experimental error) to its human homologue. The
smaller isoform may indicate another transcript with high homology to
TIP39 or to an alternatively spliced or post-transcriptionally modified TIP39 message. Post-transcriptional processing may explain the disparity between TIP39's theoretical open reading frame of 96.8 kDa
(for its human homologue) and our Western data suggesting that TIP39
codes a translated product of 39 kDa. TIP39 mRNA is expressed as
early as E14 and continues into postnatal development.
The pattern of expression of the recombinant TIP39 antibody (Fig. 4,
C and D) is similar to that seen for antibodies
directed to bovine tuftelin (Fig. 4E). At two days postnatal
(Fig. 4, C, D and E), it appears that TIP39 and
tuftelin colocalize to the apical region of the ameloblasts, to an area
known as Tomes' processes. These results support our previous notion
that TIP39 has a particular function in the cell cytoskeleton (20). The
protein localization data suggest that TIP39 may be involved in the
transport or secretion of enamel proteins into the extracellular
matrix. These observations are consistent with TIP39 being ubiquitously
expressed, being part of the cell secretory machinery, having a
physical interaction with tuftelin, and showing colocalization with
tuftelin within the enamel matrix. This also predicts that TIP39 may
have an influence on the intracellular transport of amelogenin. What
remains difficult to explain for both TIP39 and tuftelin is their
apparent extracellular location, as neither protein sequence contains a
recognizable leader peptide. Despite the lack of a leader peptide, the
presence of tuftelin and TIP39 in the extracellular matrix can be
explained in the following way. Secretory ameloblasts appear to shed
part of their Tomes' processes, including membrane phospholipids (32, 33). Intentional deposition of protein and lipid into the developing enamel, and in particular at the rod and interod boundaries, may serve
to pattern the enamel extracellular matrix and/or could act as a
boundary to mechanical stresses. Alternatively, the tuftelin·TIP complexes may play a role in anchoring ameloblasts to the
dentine-enamel junction or anchoring ameloblasts to the enamel matrix
itself. Such a protein complex may be shed during rapid secretory
activity and thus be incorporated into the enamel matrix.
In an attempt to identify a function for TIP39, a search of the gene
data bases was performed. The human homologue is located on chromosome
22q12.1, a region devoid of any known defects in mammalian physiology,
and thus it is uninformative. In addition to the human homologue of
TIP39, three other genes had significant amino acid similarities. The
first was a Drosophila melanogaster gene of unknown or
undocumented function (GenBankTM accession number
AF145670). The second was a Caenorhabditis elegans gene,
also of unknown function (document identification 3874094), that was
characterized during work on the C. elegans Genome
Sequencing Project (34). The third gene is a yeast protein (GenBankTM accession number Q09837) identified as an
integral membrane protein. By using the ClustalW Formatted Alignment
software (35) a striking pattern of similarities among the TIP39
homologues began to emerge (Table IV). The similarities at the amino
acid level suggest that four (e.g. mouse, human, fly, and
worm, see Table IV) of the five genes may be homologues and may serve
similar functions in these disparate organisms. The fifth gene, the
yeast membrane protein, although not an obvious homologue of TIP39, may
belong to the same gene family with its encoded protein product serving
a similar function. These findings suggest that TIP39 may act as a
membrane-bound protein and may participate in the secretion of
cell-specific proteins.
Initial DNA sequence homology searches for TIP39 indicated that TIP39
shared weak similarity with the human clathrin heavy chain (20). At the
protein level, TIP39 and its human homologue have a number of protein
kinase C and casein kinase 2 phosphorylation sites similar to clathrin
(36, 37). Other observations that draw our attention to clathrin for
comparisons are that both TIP39 and the clathrin heavy and clathrin
light chains have Myc-type "helix-loop-helix" dimerization domains
(38) (Table IV). Finally, TIP39 contains a clathrin-binding motif
(LIDM) at its carboxyl terminus (39) that may be suggestive of a
functional interaction between TIP39 and clathrin.
A protein analysis of mouse TIP39 and its human homologue was
performed, and coiled-coil motifs were predicted (40). For mouse TIP39,
the coiled-coils were suggested at the amino-terminal region and at the
carboxyl-terminal region (Table IV). In the human protein these
coiled-coil regions approximately equated to amino acids 300-400 and
amino acids 700-750 (Table IV). In addition, the human protein has
another predicted coiled-coil region within amino acids 200-240 (Table
IV). Mouse and bovine tuftelin proteins also have predicted coiled-coil
regions. This may imply that tuftelin and TIP39 have assembly or
self-assembly properties because helical protein domains such as
coiled-coils tend to associate with like domains (41). Tuftelin
self-assembly has previously been demonstrated at the coiled-coil
domain (19, 31). Interaction among coiled-coil domains may also explain the interactions observed between tuftelin and TIP39.
Deletion experiments were conducted in the yeast two-hybrid assay in
order to determine the protein domains involved in the protein-protein
interaction between TIP39 and tuftelin. Both mouse-derived and
bovine-derived tuftelin interact with TIP39. For mouse tuftelin, the
ability to interact with TIP39 could be defined within the carboxyl-terminal amino acids 294-390 of tuftelin. Amino acid similarities between mouse tuftelin (16) and bovine tuftelin (22) exist
up to, but not beyond, amino acid number 348. Therefore, it seems
likely that the domain of tuftelin responsible for the interaction is
contained entirely within 55 amino acids (e.g. amino acid
residues 294-348 of mouse tuftelin, Table II). Furthermore, amino acid
residues 294-348 of mouse tuftelin contain a predicted coiled-coil
region (Table IV) (40). This 55-amino acid binding domain of mouse
tuftelin relates closely to the bovine tuftelin self-assembly domain
defined previously (31) and suggests that this may be a multifunctional
structural region of the tuftelin gene product. In contrast, when
portions of TIP39 cDNA were deleted, they did not result in protein
products capable of interacting with tuftelin. These results are
consistent with the tertiary or quaternary structure of TIP39
influencing its ability to bind to tuftelin.
Enamel formation results from unique molecular activities occurring
both at the intracellular and extracellular levels. The cloning of and
in situ gene expression patterns for the TIPs in this study
(20) have contributed to this growing list of proteins that are
differentially expressed in odontogenic tissues. Additional discovery
and characterization of enamel matrix proteins can only help to define
further odontogenesis and enhance our understanding of these complex
events. Prior to secreting tooth extracellular matrix proteins,
ameloblasts and odontoblasts must define their roles and coordinate
their activities. Regulation and organization of enamel are determined
by the timing of expression and the quantities of the proteins that
comprise the enamel organic matrix. Enamel matrix proteins are produced
principally by the ameloblasts, but neighboring cells, including the
odontoblasts, also contribute to the enamel organic matrix, especially
at the dentine-enamel junction. Specific intracellular proteins may act
as chaperones to coordinate secretory events, serve as elements within
regulatory pathways, or provide structure within the cytoskeleton.
Ultimately, whether TIP39 is located intracellularly or
extracellularly, its function may be critical to the differentiation of
ameloblasts and odontoblasts or to the forming enamel extracellular
matrix. The organization of this extracellular organic matrix may in
turn be reflected in the resulting enamel mineral structure. By
determining the roles of TIPs and other tooth-related proteins, we may
better understand the synchronized events of enamel biogenesis.
We thank our colleagues at the Center for
Craniofacial Molecular Biology, University of Southern California, for
helpful discussions during this study. We also thank David Crowe, Ya
Ping Lei, Dan Hong Zhu, Benton Yoshida, Pablo Bringas, Jr., and
Valentino Santos for their help throughout these experimental procedures.
*
This work was supported by NIDCR Grants DE06988, DE07211,
DE11704, and DE13045 from the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF156852.
§
To whom correspondence should be addressed: the Center for
Craniofacial Molecular Biology, 2250 Alcazar St., CSA Rm. 142, University of Southern California School of Dentistry, Los Angeles, CA
90033-1004, Tel.: 323-4421728; Fax: 323-442-2981; E-mail:
paine@hsc.usc.edu.
Published, JBC Papers in Press, May 9, 2000, DOI 10.1074/jbc.M000118200
The abbreviations used are:
TIP, tuftelin-interacting protein;
PCR, polymerase chain reaction;
RT-PCR, reverse transcriptase-PCR;
kb, kilobase.
A Tuftelin-interacting Protein (TIP39) Localizes to the Apical
Secretory Pole of Mouse Ameloblasts*
,
§,
,
, and
Center for Craniofacial Molecular Biology,
University of Southern California School of Dentistry,
Los Angeles, California 90033-1004, the ¶ Department of
Pharmaceutical Sciences, University of Southern California School of
Pharmacy, Los Angeles, California 90033, and the
Institute of
Oral Pathology, Faculty of Dentistry, University of Oslo, P. O. Box 1109 Blindern, N-0317 Oslo, Norway
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Primers used in this study
Mouse and bovine tuftelin
Plasmids used in this study
-Galactosidase activity for multiple transformed yeast colonies is
indicated on an ordinal scale that has been defined previously (19),
where
indicates no blue color and +++ indicates a strong blue
color. Previously used positive controls (tuftelin versus
tuftelin; amelogenin versus amelogenin; p53
versus SV40 large T antigen and Ha-Ras versus
CDC25) were included.
![]()
View larger version (5K):
[in a new window]
Fig. 1.
A graphic depiction of the cloning strategy
showing restriction sites and oligonucleotide primers used to generate
plasmids pTIP-10-(1-208), pTIP-10-(1-131), pTIP-10-(193-526),
pTIP-10-(333-526), and pTIP-10-(412-526). A start (ATG) codon
signifies a theoretical open reading frame that is in the correct
reading frame and relates to amino acid number 1 in this plasmid
nomenclature.

Galactosidase
Activity--
The filter assay was used to assess 
galactosidase
activity, a parameter directly reflecting the strength of
protein-protein interactions. The experiment was performed in
triplicate, and the results were identical on all three occasions.
Complete methodology for the filter assay has been reported previously
(19). Filters were left for 24 h to develop a blue color; this
color change indicated a positive interaction between the two hybrid
proteins of interest. No color change indicated no interaction between the two hybrid proteins of interest. Negative controls involved each of
the protein hybrid constructs cotransformed with either pAD-GAL4 (for
the GAL4-binding domain tuftelin hybrids) or pAS2 (for the
GAL4-activating domain TIP39 hybrids). All negative control combinations had no discernible
-galactosidase activity as measured by the filter assay.
60
kPa. Samples were placed in plastic molds, filled with paraffin wax,
allowed to solidify overnight, and cooled before sectioning. Using a
microtome, 6-µm sagittal sections were prepared and placed on diethyl
pyrocarbonate-treated water on polylysine-coated slides. Tissue
sections were spread by placing slides on a warmer at 42 °C overnight.
20 °C. RNA was recovered and subsequently washed in 70%
EtOH and resuspended in diethyl pyrocarbonate-treated water (1 µg/µl). This RNA, the Invitrogen Cycle Kit (Invitrogen Corporation,
San Diego, CA), and oligonucleotide primers SN228 and SN209 (Table I)
were used to generate cDNA by reverse transcriptase.

View larger version (41K):
[in a new window]
Fig. 2.
Western analysis for TIP39 expression was
performed on protein extracted from molar teeth of 1-day-old mice
(lanes 1 and 4) using either the
TIP39 antibody produced against rTIP41 (lanes 1, 2, and 3) or against rTIP78 (lanes 4 and 5). Lane 3 contains rTIP41
protein only, and lane 5 contains rTIP78 protein only; these
two lanes were included as positive controls. Lanes 2 is
recombinant mouse amelogenin protein and was used as a negative
control. A protein (kDa) size marker is indicated on the
right-hand side.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
ClustalW Analysis for TIP39

galactosidase activity, thus eliminating
any possible variability in materials. In addition three different
colonies of each of the doubly transformed yeast were assessed for

galactosidase activity. This experiment, in its entirety, was
repeated three times with consistent results. Table III summarizes the
results from the double-plasmid transformations and filter assay. This
table records arbitrary ordinal scores to quantitate the strength of
interaction and is based on the rate at which the blue color developed
on the filter, and on the relative color intensity after the reaction
was complete. The ordinal scale for experimental interaction is bound
by a number of positive and negative controls that have been reported
previously (19). All negative control combinations, as described under "Experimental Procedures," showed no
-galactosidase activity after 24 h of exposure to the 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside (X-gal) solution.
-actin as a standard control.

View larger version (40K):
[in a new window]
Fig. 3.
Northern blot hybridization for TIP39.
Two 32P-labeled TIP39 cDNA probes were generated; one
covered the 5'-portion of plasmid pTIP-10 extending to the internal
XhoI restriction site (A). The second
32P-labeled probe used PCR-generated (oligonucleotide
primers SN229 and SN227) DNA as the template and covered the
3'-translated region of TIP39 (B). The regions of TIP39
cDNA covered by the 5'- and 3'-probes (thick lines), as
they relate to the plasmid pTIP-10 (thin, heavy line), are
illustrated in D. The
-actin gene served as a control to
illustrate the loading distribution of poly(A)-RNA onto the membrane
(C).

View larger version (116K):
[in a new window]
Fig. 4.
Localization of TIP39 or tuftelin in
odontogenic cells. In situ hybridization for 1-day-old
postnatal mouse mandible sections were treated with a
digoxigenin-labeled TIP39 complementary RNA antisense (A) or
sense (B) probe. Blue indicates the sites of
hybridization for the TIP39 cRNA probe (A) to its
corresponding mRNA in ameloblasts (Am), odontoblasts
(Od), and cells of the stratum intermedium (Si).
B is treated with a "control" sense probe where no
hybridization is evident. Sections were counterstained with neutral
red. Antibody produced against rTIP41 was used to localize the TIP39
protein in second molars from a 2-day-old postnatal mouse mandible
section (C and D). The presence of
antigen-antibody complex is indicated by the pink color
(C) or the red color (D). TIP39
protein localization is evident on the external surface of large
spherical inclusions (arrows) that are proximal to the
Tomes' processes (TP). TIP39 protein is also present in the
newly secreted enamel extracellular matrix (EECM). Sections
treated with only the secondary antibody produced no signal (data not
shown). E, bovine tuftelin antipeptide antibody localization
in a second molar from a 2-day-old postnatal mouse mandible section.
The presence of the antigen-antibody complex is indicated by the
red color. Tuftelin protein is present in the apical region
of the ameloblasts and in the newly secreted EECM. The
arrows point to the large spherical inclusions associated
with Tomes' processes (E). Sections treated with only the
secondary antibody produced no signal (data not shown).
F
H, immunofluorescence of mouse ameloblast-like LS8 cells.
F, expression of TIP39 (red fluorescence) using
antibodies produced against rTIP41. G, expression of
tuftelin (green fluorescence) using antibodies produced
against the mouse recombinant tuftelin protein. Colocalization is
evident when both images are superimposed (H) or when images
(F and G) are compared. Ameloblasts
(Am), odontoblasts (Od), Tomes' processes
(TP), enamel extracellular matrix (EECM), dentin
extracellular matrix (DECM), stratum intermedium
(Si), and dentino-enamel junction (DEJ) are
identified. Arrows are to the apical poles or Tomes'
processes. A and B are of the developing incisor
at × 20 magnification. C was photographed at × 100 magnification, and D and E were photographed
at × 40 magnification. F-H were each photographed
at × 100 magnification.

View larger version (65K):
[in a new window]
Fig. 5.
Developmental expression of TIP39 mRNA by
RT-PCR. Lane 2 was a PCR amplification using plasmid
TIP-10 cDNA as template and was included as a positive control with
a band evident at 604 base pairs. Lane 3 contained no RNA
template in the reverse transcriptase reaction of the RT-PCR
amplification and was used as a negative control. Lane 4, kidney RNA was the RT-PCR template; lanes 5-9, the RT-PCR
template was RNA-isolated from fetal mandibles at stages E14-E18,
respectively. Lane 10 is RNA from the mandible of mouse pups
at birth.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Fincham, A. G.,
and Moradian-Oldak, J.
(1995)
Connect. Tissue Res.
32,
119-124
2.
White, S. N.,
Paine, M. L.,
Sarikaya, M.,
Fong, H., Yu, Z.,
Li, Z. C.,
and Snead, M. L.
(2000)
J. Am. Ceram. Soc.
83,
238-240
3.
Smith, C.
(1998)
Crit. Rev. Oral Biol. Med.
9,
128-161
4.
Lowenstam, H. A.,
and Weiner, S.
(1989)
On Biomineralization
, pp. 175-188, Oxford University Press, New York
5.
Simmer, J. P.,
and Fincham, A. G.
(1995)
Crit. Rev. Oral Biol. Med.
6,
84-108
6.
Snead, M. L.,
Luo, W.,
Lau, E. C.,
and Slavkin, H. C.
(1988)
Development
104,
77-85
7.
Thesleff, I.,
Vaahtokari, A.,
and Partanen, A. M.
(1995)
Int. J. Dev. Biol.
39,
35-50
8.
Slavkin, H. C.,
Hu, C. C.,
Sakakura, Y.,
Diekwisch, T.,
Chai, Y.,
Mayo, M.,
Bringas, J., P.,
Simmer, J.,
Mak, G.,
Sasano, Y.,
and David, S.
(1992)
Crit. Rev. Eukaryotic Gene Expr.
2,
315-329
9.
Maas, R.,
and Bei, M.
(1997)
Crit. Rev. Oral Biol. Med.
8,
4-39
10.
Simmer, J. P.,
and Snead, M. L.
(1995)
in
Dental Enamel: Formation to Destruction
(Robinson, C.
, Kirkham, J.
, and Shore, R., eds)
, pp. 59-84, CRC Press, Inc., Boca Raton, FL
11.
Krebsbach, P. H.,
Lee, S. K.,
Matsuki, Y.,
Kozac, C.,
Yamada, K. M.,
and Yamada, Y.
(1996)
J. Biol. Chem.
271,
4431-4435
12.
Fong, C. D.,
Cerny, R.,
Hammarstrom, L.,
and Slaby, I.
(1998)
Eur. J. Oral Sci.
106 Suppl. 1,
324-330
13.
Hu, C.-C.,
Simmer, J. P.,
Bartlett, J. D.,
Qian, Q.,
Zhang, C.,
Ryu, O. H.,
Xue, J.,
Fukae, M.,
Uchida, T.,
and MacDougall, M.
(1998)
Connect. Tissue Res.
39,
351-365
14.
Deutsch, D.,
Palmon, A.,
Dafni, L.,
Catalano-Sherman, J.,
Young, M. F.,
and Fisher, L. W.
(1995)
Int. J. Dev. Biol.
39,
135-143
15.
Bashir, M. M.,
Abrams, W. R.,
and Rosenbloom, J.
(1997)
Arch. Oral Biol.
42,
489-496
16.
MacDougall, M.,
Simmons, D.,
Dodds, A.,
Knight, C.,
Luan, X.,
Zeichner-David, M.,
Zhang, C.,
Ryu, O. H.,
Qian, Q.,
Simmer, J. P.,
and Hu, C. C.
(1998)
J. Dent. Res.
77,
1970-1978
17.
Fincham, A. G.,
Moradian-Oldak, J.,
Diekwisch, T. G. H.,
Lyaruu, D. M.,
Wright, J. T.,
Bringas, P., Jr.,
and Slavkin, H. C.
(1995)
J. Struct. Biol.
115,
50-59
18.
Zeichner-David, M.,
Vo, H.,
Tan, H.,
Diekwisch, T.,
Berman, B.,
Theimann, F.,
Alcocer, M. D.,
Hsu, P.,
Wang, T.,
Enya, J.,
Caton, J.,
Slavkin, H. C.,
and MacDougall, M.
(1997)
Int. J. Dev. Biol.
41,
27-38
19.
Paine, M. L.,
Krebsbach, P. H.,
Chen, L. S.,
Paine, C. T.,
Yamada, Y.,
Deutsch, D.,
and Snead, M. L.
(1998)
J. Dent. Res.
77,
496-502
20.
Paine, C. T.,
Paine, M. L.,
and Snead, M. L.
(1998)
Connect. Tissue Res.
38,
257-267
21.
Tabor, S.,
and Richardson, C. C.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4767-4771
22.
Deutsch, D.,
Palmon, A.,
Fisher, L. W.,
Kolodny, N.,
Termine, J. D.,
and Young, M. F.
(1991)
J. Biol. Chem.
266,
16021-16028
23.
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
24.
Wilkinson, D. G.
(1992)
in
In Situ Hybridization: A Practical Approach
(Rickwood, D.
, and Hames, B. D., eds)
, IRL Press at Oxford University Press, Oxford
25.
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1990)
Current Protocols in Molecular Biology
, pp. 11.0.1-11.17.13, Wiley Interscience, New York
26.
Simmer, J. P.,
Lau, E. C.,
Hu, C. C.,
Aoba, T.,
Lacey, M.,
Nelson, D.,
Zeichner-David, M.,
Snead, M. L.,
Slavkin, H. C.,
and Fincham, A. G.
(1994)
Calcif. Tissue Int.
54,
312-319
27.
Chen, L. S.,
Couwenhoven, D.,
Hsu, D.,
Luo, W.,
and Snead, M. L.
(1992)
Arch Oral Biol.
37,
771-778
28.
Dhamija, S.,
Liu, Y.,
Yamada, Y.,
Snead, M. L.,
and Krebsbach, P. H.
(1999)
J. Biol. Chem.
274,
20738-20743
29.
Kume, K.,
Zylka, M. J.,
Sriram, S.,
Shearman, L. P.,
Weaver, D. R.,
Jin, X.,
Maywood, E. S.,
Hastings, M. H.,
and Reppert, S. M.
(1999)
Cell
98,
193-205
30.
Paine, M. L.,
and Snead, M. L.
(1997)
J. Bone Min. Res.
12,
221-227
31.
Paine, M. L.,
Deutsch, D.,
and Snead, M. L.
(1997)
Connect. Tissue Res.
35,
157-161
32.
Goldberg, M.,
LeColle, S.,
Bissila-Mapahou, P.,
Septier, D.,
and Carreau, J. P.
(1996)
Adv. Den. Res.
10,
126-134
33.
Goldberg, M.,
Lecolle, S.,
Vermelin, L.,
Benghezal, A.,
and Godeau, G.
(1999)
Calcif. Tissue Int.
65,
66-72
34.
Wilson, R.,
Ainscough, R.,
Anderson, K.,
Baynes, C.,
Berks, M.,
Bonfield, J.,
Burton, J.,
Connell, M.,
Copsey, T.,
Cooper, J.,
Coulson, A.,
Craxton, M.,
Dear, S.,
Du, Z.,
Durbin, R.,
Favello, A.,
Frazer, A.,
Fulton, L.,
Gardner, G.,
Green, P.,
Hawkins, T.,
Hillier, L.,
Jler, M.,
Johnston, L.,
Jones, M.,
Kershaw, J.,
Kirsten, J.,
Laisster, N.,
Latreille, P.,
Lightning, J.,
Lloyd, C.,
Mortimore, B.,
O'Callaghan, M.,
Parsons, J.,
Percy, C.,
Rifken, L.,
Roopra, A.,
Saunders, D.,
Shownkeen, R.,
Sims, M.,
Smaldon, N.,
Smith, A.,
Smith, M.,
Sonnhammer, E.,
Staden, R.,
Sulston, J.,
Thierry-Mieg, J.,
Thomas, K.,
Vaudin, M.,
Vaughan, K.,
Waterston, R.,
Weinstock, L.,
Wilkinson-Sproat, J.,
and Wohidman, P.
(1994)
Nature
368,
32-38
35.
Karlin, S.,
and Altschul, S. F.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2264-2268
36.
Allende, J. E.,
and Allende, C. C.
(1995)
FASEB J.
9,
313-323
37.
Pinna, L. A.
(1997)
Int. J. Biochem. Cell Biol.
29,
551-554
38.
Bairoch, A.,
Bucher, P.,
and Hofmann, K.
(1997)
Nucleic Acids Res.
25,
217-221
39.
Wendland, B.,
Steece, K. E.,
and Emr, S. D.
(1999)
EMBO J.
18,
4383-4393
40.
Lupas, A.,
Van Dyke, M.,
and Stock, J.
(1991)
Science
252,
1162-1164
41.
Stryer, L.
(1988)
Biochemistry
, 3rd. Ed.
, p. 27, W. H. Freeman & Co., New York, 925
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M.L. Paine, M.L. Snead, H.J. Wang, N. Abuladze, A. Pushkin, W. Liu, L.Y. Kao, S.M. Wall, Y.-H. Kim, and I. Kurtz Role of NBCe1 and AE2 in Secretory Ameloblasts J. Dent. Res., April 1, 2008; 87(4): 391 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Paine, W. Luo, H.-J. Wang, P. Bringas Jr., A. Y. W. Ngan, V. G. Miklus, D.-H. Zhu, M. MacDougall, S. N. White, and M. L. Snead Dentin Sialoprotein and Dentin Phosphoprotein Overexpression during Amelogenesis J. Biol. Chem., September 9, 2005; 280(36): 31991 - 31998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Slayton, M.E. Cooper, and M.L. Marazita Tuftelin, Mutans Streptococci, and Dental Caries Susceptibility J. Dent. Res., August 1, 2005; 84(8): 711 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Paine, H.-J. Wang, W. Luo, P. H. Krebsbach, and M. L. Snead A Transgenic Animal Model Resembling Amelogenesis Imperfecta Related to Ameloblastin Overexpression J. Biol. Chem., May 23, 2003; 278(21): 19447 - 19452. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||